CPT® Code 80178 is used to report quantitative therapeutic drug monitoring of lithium levels in a patient's blood. Lithium is commonly prescribed for the treatment of bipolar disorder and other mood disorders, and regular monitoring is essential because the drug has a narrow therapeutic range.
Testing helps providers ensure that lithium levels remain therapeutic while minimizing the risk of toxicity and adverse effects.
This code represents the laboratory analysis only, not specimen collection, interpretation, or evaluation and management services.
Key Facts About CPT® 80178
- Service type: Laboratory test (therapeutic drug monitoring)
- Test: Lithium level measurement
- Specimen type: Serum or plasma
- Test purpose: Monitor therapeutic drug levels and assess toxicity risk
- Provider type: Laboratories, physicians, and qualified healthcare professionals
Common clinical indications:
- Bipolar disorder management
- Monitoring lithium therapy effectiveness
- Evaluation of suspected lithium toxicity
- Medication dosage adjustments
- Ongoing psychiatric medication management
When to Use CPT® 80178
CPT 80178 is appropriate when:
- Measuring blood lithium concentrations in patients receiving lithium therapy
- Monitoring treatment effectiveness and medication adherence
- Evaluating potential lithium toxicity
- Adjusting lithium dosage based on laboratory results and clinical response
Examples:
- Routine monitoring of a patient receiving maintenance lithium therapy for bipolar disorder
- Checking lithium levels after a dosage adjustment
- Evaluating symptoms suggestive of lithium toxicity, such as tremors or confusion
- Monitoring lithium levels in patients with changing renal function or medication regimens
Documentation Requirements
To support CPT 80178 billing, documentation should include:
- Patient identifiers and date of service
- Clinical indication for testing
- Current lithium therapy information, when applicable
- Specimen type (serum or plasma)
- Test performed (lithium level measurement)
- Test result and date reported
- Ordering provider information
Clear documentation supports medical necessity and continuity of care.
Reimbursement and Coding Considerations
- CPT 80178 is generally covered when medically necessary for patients receiving lithium therapy
- Diagnosis coding should support mood disorders, bipolar disorder, or therapeutic drug monitoring
- Often performed periodically due to lithium's narrow therapeutic index
- May be ordered alongside renal function, thyroid function, or electrolyte testing
- Frequency limitations may apply depending on payer policy and clinical circumstances
Always verify payer-specific laboratory and therapeutic drug monitoring requirements.
How OptiMantra Supports Therapeutic Drug Monitoring
OptiMantra’s integrated EMR and practice management system streamlines documentation and billing for CPT 80178:
With OptiMantra, providers can:
- Order lithium testing within the patient chart
- Track lithium levels longitudinally over time
- Link laboratory results to medication management plans
- Maintain organized laboratory documentation that supports billing compliance and audit preparedness
- Monitor treatment effectiveness and patient safety through integrated workflows
- Consolidate laboratory data, prescriptions, and follow-up care within a single platform
By centralizing medication management and laboratory monitoring, OptiMantra helps practices improve efficiency, ensure compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
